Immunosys

Executive Summary

ImmunoSYS is a UK-based immunology and protein biology consulting firm founded in 2016. With over 20 years of collective experience, the company provides specialized services including immune modelling, novel in vitro human studies, and method development for preclinical research. Targeting the biopharma industry, ImmunoSYS supports clients in advancing immunology and infectious disease programs. The firm operates as a private, pre-clinical stage company, focusing on expert consulting rather than proprietary product development. As a niche consultancy, ImmunoSYS benefits from growing demand for outsourced immunology expertise. However, its growth is dependent on securing client contracts and expanding its service portfolio. While the company has established a technical foundation, its scalability is limited by the consulting business model. Key risks include competition from larger CROs and reliance on a small team. Nonetheless, its deep scientific expertise positions it as a valuable partner for biotech and pharma companies seeking tailored immunology support.

Upcoming Catalysts (preview)

• Q3 2026New Strategic Partnerships with Pharmaceutical Companies60% success
• Q4 2026Expansion of Service Offerings into Autoimmune Disease Modelling50% success
• Q2 2026Recruitment of Key Scientific Advisors or Directors70% success